Abstract
Four patients with Friedreich's ataxia took part in an open trial, in which they consumed 50-100g/day lecithin granules (containing approximately 22% phosphatidycholine) for 16 weeks, but no improvement resulted. Several unwanted effects including diarrhoea, nausea, depression, "hot flushes" and weakness were experienced. Resting levels of free-choline in plasma were within the range found in 19 normal subjects. Sixteen other patients with Friedreich's ataxia also had normal free-choline levels. Treatment with lecithin significantly increased plasma free-choline levels, but there was a trend for these to fall towards baseline levels, despite continued ingestion of lecithin.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barbeau A. Lecithin in neurologic disorders. N Engl J Med. 1978 Jul 27;299(4):200–201. doi: 10.1056/NEJM197807272990414. [DOI] [PubMed] [Google Scholar]
- Barbeau A., Melançon S., Butterworth R. F., Filla A., Izumi K., Ngo T. T. Pyruvate dehydrogenase complex in Friedreich's ataxia. Adv Neurol. 1978;21:203–217. [PubMed] [Google Scholar]
- Eckernäs S. A., Aquilonius S. M. Free choline in human plasma analysed by simple radio-enzymatic procedure: age distribution and effect of a meal. Scand J Clin Lab Invest. 1977 Apr;37(2):183–187. doi: 10.1080/00365517709156075. [DOI] [PubMed] [Google Scholar]
- Etienne P., Gauthier S., Johnson G., Collier B., Mendis T., Dastoor D., Cole M., Muller H. F. Clinical effects of choline in Alzheimer's disease. Lancet. 1978 Mar 4;1(8062):508–509. doi: 10.1016/s0140-6736(78)90180-0. [DOI] [PubMed] [Google Scholar]
- Geoffroy G., Barbeau A., Breton G., Lemieux B., Aube M., Leger C., Bouchard J. P. Clinical description and roentgenologic evaluation of patients with Friedreich's ataxia. Can J Neurol Sci. 1976 Nov;3(4):279–286. doi: 10.1017/s0317167100025464. [DOI] [PubMed] [Google Scholar]
- Gibson G. E., Jope R., Blass J. P. Decreased synthesis of acetylcholine accompanying impaired oxidation of pyruvic acid in rat brain minces. Biochem J. 1975 Apr;148(1):17–23. doi: 10.1042/bj1480017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Growdon J. H., Gelenberg A. J., Doller J., Hirsch M. J., Wurtman R. J. Lecithin can suppress tardive dyskinesia. N Engl J Med. 1978 May 4;298(18):1029–1030. [PubMed] [Google Scholar]
- Hanin I. Choline and lecithin in the treatment of neurologic disorders. N Engl J Med. 1979 May 10;300(19):1113–1113. doi: 10.1056/NEJM197905103001915. [DOI] [PubMed] [Google Scholar]
- Hirsch M. J., Growdon J. H., Wurtman R. J. Increase in hippocampal acetylcholine after choline administration. Brain Res. 1977 Apr 15;125(2):383–385. doi: 10.1016/0006-8993(77)90634-5. [DOI] [PubMed] [Google Scholar]
- Kark R. A., Blass J. P., Spence M. A. Physostigmine in familial ataxias. Neurology. 1977 Jan;27(1):70–72. doi: 10.1212/wnl.27.1.70. [DOI] [PubMed] [Google Scholar]
- Kark R. A., Rodriguez-Budelli M., Blass J. P. Evidence for a primary defect of lipoamide dehydrogenase in Friedreich's ataxia. Adv Neurol. 1978;21:163–180. [PubMed] [Google Scholar]
- Livingstone I. R., Mastaglia F. L. Choline chloride in the treatment of ataxia. Br Med J. 1979 Oct 13;2(6195):939–939. doi: 10.1136/bmj.2.6195.939. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith C. M., Swash M., Exton-Smith A. N., Phillips M. J., Overstall P. W., Piper M. E., Bailey M. R. Choline therapy in Alzheimer's disease. Lancet. 1978 Aug 5;2(8084):318–318. doi: 10.1016/s0140-6736(78)91721-x. [DOI] [PubMed] [Google Scholar]
- Ulus I. H., Wurtman R. J. Choline administration: activation of tyrosine hydroxylase in dopaminergic neurons of rat brain. Science. 1976 Dec 3;194(4269):1060–1061. doi: 10.1126/science.10629. [DOI] [PubMed] [Google Scholar]
- Wang F. L., Haubrich D. R. A simple, sensitive, and specific assay for free choline in plasma. Anal Biochem. 1975 Jan;63(1):195–201. doi: 10.1016/0003-2697(75)90204-3. [DOI] [PubMed] [Google Scholar]